Vivos Therapeutics VVOS

NASDAQ VVOS
$0.18 0.00 (-0.72%)
As of: Sep 9, 2026 · 10:37 AM EDT
Key Stats
Market Cap3.04 Mn
P/E-0.12
P/S0.15
Div. Yield0.00
Total Debt (Qtr)8.14 Mn
Revenue Growth (1y) (Qtr)34.90
Add ratio to table…

About

Vivos Therapeutics Inc is a revenue stage medical technology and healthcare services company that offers a comprehensive suite of proprietary oral appliances and therapeutic treatments known as the Vivos Method. The Vivos Method non surgically treats maxillofacial and developmental abnormalities of the mouth and jaws that are linked to breathing and sleep disorders such as obstructive sleep apnea and snoring in adults. The company also provides diagnostic and treatment…

Read more ↓
Sector: Healthcare Sector rationale The company's primary revenue is derived from medical technology (FDA-cleared oral appliances) and healthcare services (diagnostic and treatment services at Sleep and Airway Medicine Centers). It specifically targets the treatment of obstructive sleep apnea and snoring, fitting squarely within the Medical Devices and Healthcare Services industries. Industries: Dental Dental Primary Vivos Therapeutics sells proprietary oral appliances (such as Versa, Vida, and Tooth Positioners) and operates dental service organizations to treat maxillofacial abnormalities. Its core product is a non-surgical dental-based therapy for obstructive sleep apnea and snoring. Healthcare Services Healthcare Services Secondary The company operates Sleep and Airway Medicine Centers that provide diagnostic and treatment services, including sleep testing, and manages sleep medical practices via management services organizations. Diagnostic Equipment Diagnostic Equipment Secondary Vivos generates revenue from leasing SleepImage home sleep test recorders, which are diagnostic equipment used to identify sleep disorders. Classified using BQ-MICS CIK: 0001716166

Product and Service Breakdown of Revenue (2025)

Peer group

Peer Comparison

Companies in the Dental
S.No. Ticker Company matchMarket CapP/EP/STotal Debt (Qtr)
1 ALGN Align Technology Inc primary10.84 Bn26.222.62-
2 NVST Envista Holdings Corp primary4.31 Bn45.371.511.44 Bn
3 XRAY DENTSPLY SIRONA Inc. primary2.18 Bn-3.980.602.22 Bn
4 MLSS Milestone Scientific Inc. primary0.04 Bn-8.364.29-
5 DROR Dror Ortho-Design, Inc. primary0.01 Bn-3.95-0.00 Bn
6 VVOS Vivos Therapeutics, Inc. primary0.00 Bn-0.120.150.01 Bn
7 UNH Unitedhealth Group Inc secondary342.78 Bn22.990.7673.33 Bn
8 TMO Thermo Fisher Scientific Inc. secondary223.25 Bn31.714.8245.65 Bn